Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact

Abstract

Corresponding author : Vincent Wai-Sun Wong Department of Medicine and Therapeutics, Prince of Wales Hospital, 9/F, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR, China Tel: +852-3505-1205, Fax: +852-2637-3852 E-mail: [email protected] https://orcid.org/0000-0003-2215-9410 Abbreviations: AASLD, American Association for the Study of Liver Diseases; ALT, alanine aminotransferase; CHB, chronic hepatitis B; EASL, European Association for the Study of the Liver; FIB-4, fibrosis-4; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma